John Wilkin
Stock Analyst at Craig-Hallum
(3.00)
# 1,493
Out of 5,043 analysts
5
Total ratings
80%
Success rate
47.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $11.93 | +0.58% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $17.08 | -12.18% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $35.97 | +25.12% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $9.58 | -16.49% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $8.06 | +259.80% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $11.93
Upside: +0.58%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $17.08
Upside: -12.18%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $35.97
Upside: +25.12%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $9.58
Upside: -16.49%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $8.06
Upside: +259.80%